Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Gilead Sciences, Inc. GILD

Healthcare  —  Drug Manufacturers General
150.93 1.24 0.83% as of 25 Sep
Market cap
$183.2B
P/E
0.0×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Gilead Sciences, Inc. (GILD) P/B ratio

As of 25 September 2026, Gilead Sciences, Inc. (GILD) trades at a P/B ratio of 16.0×. Over the past ten years it has ranged from 3.4× (December 2018) to 16.2× (September 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers General industry median of 5.0× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 6.8× 12.80%
FY2024 6.0× 31.06%
FY2023 4.6× (9.62%)
FY2022 5.1× 16.70%
FY2021 4.3× 7.73%
FY2020 4.0× 10.31%
FY2019 3.6× (3.36%)
FY2018 3.8× (20.19%)
FY2017 4.7× (7.88%)
FY2016 5.1× (33.84%)

Quarterly

Period P/B ratio Change
Jun 2026 13.4× 81.01%
Mar 2026 7.4× 9.43%
Dec 2025 6.8× 4.98%
Sep 2025 6.4× (8.73%)
42 more quarters

Against its own ten years

Low 3.4× High 16.2×
Ten-year median 4.6×
Current reading's percentile 100

P/B ratio against peers

Company P/B ratio
SNY Sanofi compare 1.2×
PFE Pfizer Inc. compare 1.9×
GSK GSK PLC Sponsored ADR compare 4.3×
NVO Novo Nordisk A/S compare 5.0×
AZN AstraZeneca PLC compare 5.1×
BMY Bristol Myers Squibb Company compare 5.8×
NVS Novartis AG compare 6.6×
GILD Gilead Sciences, Inc. 16.0×
AMGN Amgen Inc. compare 19.2×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on GILD